Svoronos Dawn bought XENE
June 1, 2026 · Form 4 insider transaction
Svoronos Dawn bought 2,645 shares of Xenon Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,645
Price
N/A
Total value
N/A
InsiderSvoronos Dawn
RoleDirector
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after27,645
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders.